BAQSIMI™ Glucagon 3 mg Powder

Name: Glycogenolytic Agent
Brand: BAQSIMI™

BAQSIMI, PDR NASAL SPR 3MG (2/CT)

No Image

Compare

Features

BAQSIMI® is indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above
Nasal powder: intranasal device containing one dose of glucagon 3 mg
Dry nasal powder form of glucagon
More …

Product Details Email

Subject: McKesson-Medical Surgical - Product Details #1253677

McKesson Item #1253677

BAQSIMI™ Glucagon 3 mg Powder

Email To You may enter multiple email addresses separated by semicolons.

Email From

Message

Characters Left: 255

Send

View Alternatives

Product Specifications
Frequently Viewed Together

Product Specifications

McKesson #

1253677

Manufacturer #

00548835202

Brand

BAQSIMI™

Manufacturer

Amphastar Pharma

Country of Origin

Unknown

Alternate Manufacturer Number

2896884

Application

Glycogenolytic Agent

Buy American Act (BAA) Compliant

Container Type

Nasal Spray Device

Dosage Form

Powder

Generic Drug Code

46726

Generic Drug Name

Glucagon

NDC Number

00548835202

Strength

3 mg

Trade Agreement Act (TAA) Compliant

UNSPSC Code

51183602

Features

BAQSIMI® is indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above
Nasal powder: intranasal device containing one dose of glucagon 3 mg
Dry nasal powder form of glucagon
2 Count